Mitsubishi Tanabe Pharma Corporation (MTPC) is seeking approval to manufacture and market MT-1186, an oral formulation of edaravone, in Japan…
Articles by Lindsey Shapiro, PhD
University of Sydney neurologist Matthew Kiernan, PhD, has been granted the 2022 Sheila Essey Award for his groundbreaking research, aimed…
Note: This story was updated April 4, 2022, to clarify that 700 participants, including both ALS patients and healthy…
Dosing has begun in a Phase 2/3 trial of SLS-005, Seelos Therapeutics’ infusion therapy to slow progression…
A company called ProJenX has been launched and will focus on the clinical development of treatments for brain diseases,…
Health Canada has authorized a new drug submission for masitinib — AB Science’s add-on therapy for amyotrophic…
A U.S. Food and Drug Administration (FDA) advisory committee has scheduled a virtual meeting with Amylyx Pharmaceuticals to review its…
NP001 slowed functional and lung declines in a subset of middle-aged patients with amyotrophic lateral…
Urine levels of neopterin, a marker of inflammation, are linked to disease progression in people with amyotrophic lateral sclerosis…
The U.S. Food and Drug Administration (FDA) has approved a Phase 2 clinical trial of the psychedelic ketamine, PharmaTher’s…